Contribution of the complement control protein modules of C2 in C4b binding assessed by analysis of C2/factor B chimeras.
To identify the complement control protein (CCP) module(s) of C2 that are required for C4b recognition, we constructed a panel of C2/factor B chimeras by substituting intact or partial factor B CCP modules for the corresponding ones of C2. Epitope mapping indicated that the anti-C2b mAb 3A3.3, which inhibits binding of C2 to C4b, reacts with the second CCP of C2 and similarly the anti-Ba mAb HA4-1A, which inhibits binding of factor B to C3b, reacts with the second CCP of factor B. The hemolytic activity of the chimeras CP1, CP2, and CP3a containing CCP1, CCP2, and a fragment of CCP3 of factor B, respectively, was substantially decreased compared with that of wild-type C2. The CP3 and CP1-3 chimeras, in which CCP3 and all three CCP modules of factor B, respectively, were substituted, had no hemolytic activity. Loss of activity could be attributed to the resistance of these two chimeras to C1s cleavage, which was probably due to conformational changes of the cleavage site. The combined results indicate that all three CCP modules of C2 contribute structural elements to the C4b-binding site of C2b. This site has been shown previously to be necessary for the initial binding of C2 to C4b which leads to the formation of the classical pathway C3 convertase.
Xu
Y
Y
Department of Medicine, University of Alabama at Birmingham, 35294, USA.
Volanakis
J E
JE
D000911:Antibodies, Monoclonal; D001483:Base Sequence; D002678:Chimera; D003175:Complement C2 / Q000032:analysis* / Q000502:physiology*; D003179:Complement C3b / Q000276:immunology; D015935:Complement C4b / Q000276:immunology*; D011415:Complement Factor B / Q000032:analysis* / Q000276:immunology; D003171:Complement Pathway, Classical; D000939:Epitopes / Q000032:analysis; D006801:Humans; D008969:Molecular Sequence Data
D000911:Antibodies, Monoclonal; D003175:Complement C2; D000939:Epitopes; D003179:Complement C3b; D015935:Complement C4b; D011415:Complement Factor B